Impact of a Tele-rehabilitation Program on People With Multiple Sclerosis
Telerehab
1 other identifier
interventional
75
1 country
1
Brief Summary
The goal of this clinical trial is to assessing safety and the occurrence of adverse effects during tele-rehabilitation (TRHB) in people with multiple sclerosis with an EDSS score of 6.5 or lower. The main questions it aims to answer are:
- Intervention using TRHB is considered safe and without adverse effects.
- Intervention using TRHB has a high degree of self-adherence, an impact on physical activity levels and self-efficacy in exercise, and a positive effect on quality of life, mood, and perception of fatigue. Researchers will compare the tele-rehabilitation with rehabilitation based solely on physical activity recommendations. Participants will complete three weekly online rehabilitation sessions and must attend three follow-up visits.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable multiple-sclerosis
Started Feb 2025
Shorter than P25 for not_applicable multiple-sclerosis
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 10, 2025
CompletedFirst Submitted
Initial submission to the registry
July 4, 2025
CompletedFirst Posted
Study publicly available on registry
September 17, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2025
CompletedSeptember 17, 2025
September 1, 2025
8 months
July 4, 2025
September 10, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Adverse events
Adverse events such as falls, pain, fatigue, and others that may occur.
From enrollment to the end of treatment in week 8
Secondary Outcomes (4)
Multiple Sclerosis Quality of Life 54
(T1) baseline, (T2) after the 8 week, (T3) at 16 week.
10 meters walking test
(T1) baseline, (T2) after the 8 week, (T3) at 16 week.
6 minute walking test
(T1) baseline, (T2) after the 8 week, (T3) at 16 week.
Berg Balance Scale
(T1) baseline, (T2) after the 8 week, (T3) at 16 week.
Study Arms (2)
Intervention group: tele-rehabilitation
EXPERIMENTALThis group will do online rehabilitation three times a week. Every two weeks, an assessment will be made to determine whether to increase the intensity of the exercise
Control group: physical activity recommendations
NO INTERVENTIONThis group will only have access to basic recommendations for physical activity.
Interventions
Adverse events are observed during online rehabilitation with computer vision technology in patients with MS.
Eligibility Criteria
You may qualify if:
- Patients diagnosed with multiple sclerosis confirmed using the 2017 McDonald criteria.
- Patients who have the technological means to conduct online sessions and the autonomy to do so.
- Patients with cognitive capacity that allows them to sign the informed consent form.
- Patients with an internet connection and a device compatible with the Rehub tele-rehabilitation platform (desktop computer, laptop, or tablet).
- EDSS level less than or equal to 6.5.
You may not qualify if:
- Participants who are currently undergoing RHB at a center.
- Participants who have undergone RHB during the two months prior to the start of the program.
- Patients with physical or mental comorbidities that may limit their participation in the rehabilitation program.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Multiple Sclerosis Center of Catalonia
Barcelona, 08035, Spain
Related Publications (5)
Yau T, McIntyre M, Chan J, Bhogal D, Andreoli A, Bayley M, Leochico CFD, Kua A, Guo M, Munce S. Adverse events associated with the delivery of telerehabilitation: A scoping review protocol. PLoS One. 2024 Feb 21;19(2):e0297908. doi: 10.1371/journal.pone.0297908. eCollection 2024.
PMID: 38381732RESULTDoherty F, Lynch P, Powell P, Monaghan K. Feasibility and effectiveness of telerehabilitation on mobility and balance function in multiple sclerosis: A systematic review and meta-analysis. J Neurol Sci. 2024 Nov 15;466:123214. doi: 10.1016/j.jns.2024.123214. Epub 2024 Sep 4.
PMID: 39270413RESULTXiang XM, Bernard J. Telehealth in Multiple Sclerosis Clinical Care and Research. Curr Neurol Neurosci Rep. 2021 Feb 28;21(4):14. doi: 10.1007/s11910-021-01103-4.
PMID: 33646409RESULTHarkey LC, Jung SM, Newton ER, Patterson A. Satisfacció del pacient amb la telesalud en entorns rurals: una revisió sistemàtica. Revista Internacional de Telerehabilitació. 2020;12(2):53-64. doi: 10.5195/ijt.2020.6303
RESULTFjeldstad-Pardo C, Thiessen A, Pardo G. Telerehabilitation in Multiple Sclerosis: Results of a Randomized Feasibility and Efficacy Pilot Study. Int J Telerehabil. 2018 Dec 11;10(2):55-64. doi: 10.5195/ijt.2018.6256. eCollection 2018 Fall.
PMID: 30588276RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Edwin R Meza Murillo, Dr
Multiple Sclerosis Center of Catalonia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- DR
Study Record Dates
First Submitted
July 4, 2025
First Posted
September 17, 2025
Study Start
February 10, 2025
Primary Completion
September 30, 2025
Study Completion
September 30, 2025
Last Updated
September 17, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share